920 related articles for article (PubMed ID: 23769659)
1. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
2. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
3. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
[TBL] [Abstract][Full Text] [Related]
5. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
7. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
[TBL] [Abstract][Full Text] [Related]
8. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
9. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation.
Gatt A; van Veen JJ; Bowyer A; Woolley AM; Cooper P; Kitchen S; Makris M
Br J Haematol; 2008 Sep; 142(6):946-52. PubMed ID: 18573110
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
[TBL] [Abstract][Full Text] [Related]
11. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding.
Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612
[TBL] [Abstract][Full Text] [Related]
12. Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation.
Jaffer IH; Stafford AR; Fredenburgh JC; Whitlock RP; Chan NC; Weitz JI
J Am Heart Assoc; 2015 Aug; 4(8):e002322. PubMed ID: 26304938
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Jonsson M; Hillarp A; Svensson P
Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
[TBL] [Abstract][Full Text] [Related]
14. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Am J Clin Pathol; 2013 Mar; 139(3):370-9. PubMed ID: 23429374
[TBL] [Abstract][Full Text] [Related]
15. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
[TBL] [Abstract][Full Text] [Related]
16. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
Nilsson CU; Strandberg K; Reinstrup P
Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
Thromb Res; 2015 Feb; 135(2):388-93. PubMed ID: 25555316
[TBL] [Abstract][Full Text] [Related]
18. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
[TBL] [Abstract][Full Text] [Related]
19. Optimizing warfarin reversal--an ex vivo study.
Gatt A; Riddell A; van Veen JJ; Kitchen S; Tuddenham EG; Makris M
J Thromb Haemost; 2009 Jul; 7(7):1123-7. PubMed ID: 19575759
[TBL] [Abstract][Full Text] [Related]
20. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment.
Kim SY; Kim JE; Kim YJ; Han KS; Kim HK
J Gastroenterol Hepatol; 2015 Apr; 30(4):784-93. PubMed ID: 25303721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
